source
- Precision Neuroscience raises $250M in Series D to expand brain-computer interface programPrecision Neurosciences announced a $250 million Series D financing round that was oversubscribed. The capital injection follows previous rounds that have brought the company’s total funding to $43…
- Genentech CEO Ashley Magargee reflects on biotech origins and future amid growing startup ecosystemGenentech’s founder story was revisited in a recent interview with CEO Ashley Magargee. She recalled how co‑founder Herbert Boyer was initially skeptical of a brief meeting with venture capitalist…